Filing Details
- Accession Number:
- 0001609351-18-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-24 16:30:26
- Reporting Period:
- 2018-04-20
- Accepted Time:
- 2018-04-24 16:30:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1609351 | Spark Therapeutics Inc. | ONCE | Biological Products, (No Disgnostic Substances) (2836) | 462654405 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1691218 | John Furey | 3737 Market Street Suite 1300 Philadelphia PA 19104 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-04-20 | 6,723 | $49.74 | 6,723 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-04-20 | 6,723 | $82.50 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-04-20 | 6,723 | $0.00 | 6,723 | $49.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
120,000 | 2026-11-30 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
- 25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017.